This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Sgambati MLM, Devesa S . Chronic Lymphocytic Leukemia, Epidemiological, Familiar, and Genetic Aspects. Bruce Cheson, Ed Marcel Dekker, Inc: New York, 2001, pp 33–62.
Fabbri G, Rasi S, Rossi D, Trifonov V, Khiabanian H, Ma J et al. Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation. J Exp Med 2011; 208: 1389–1401.
Puente XS, Pinyol M, Quesada V, Conde L, Ordonez GR, Villamor N et al. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature 2011; 475: 101–105.
Balatti V, Bottoni A, Palamarchuk A, Alder H, Rassenti LZ, Kipps TJ et al. NOTCH1 mutations in CLL associated with trisomy 12. Blood 2012; 119: 329–331.
Aster JC, Blacklow SC, Pear WS . Notch signalling in T-cell lymphoblastic leukaemia/lymphoma and other haematological malignancies. J Pathol 2011; 223: 262–273.
Koch U, Radtke F . Notch in T-ALL: new players in a complex disease. Trends Immunol 2011; 32: 434–442.
Palomero T, Lim WK, Odom DT, Sulis ML, Real PJ, Margolin A et al. NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth. Proc Natl Acad Sci USA 2006; 103: 18261–18266.
Pekarsky Y, Palamarchuk A, Maximov V, Efanov A, Nazaryan N, Santanam U et al. Tcl1 functions as a transcriptional regulator and is directly involved in the pathogenesis of CLL. Proc Natl Acad Sci USA 2008; 105: 19643–19648.
Harper JW, Elledge SJ, Keyomarsi K, Dynlacht B, Tsai LH, Zhang P et al. Inhibition of cyclin-dependent kinases by p21. Mol Biol Cell 1995; 6: 387–400.
Mullican SE, Zhang S, Konopleva M, Ruvolo V, Andreeff M, Milbrandt J et al. Abrogation of nuclear receptors Nr4a3 and Nr4a1 leads to development of acute myeloid leukemia. Nat Med 2007; 13: 730–735.
Tanoue T, Moriguchi T, Nishida E . Molecular cloning and characterization of a novel dual specificity phosphatase, MKP-5. J Biol Chem 1999; 274: 19949–19956.
Stawowczyk M, Van Scoy S, Kumar KP, Reich NC . The interferon stimulated gene 54 promotes apoptosis. J Biol Chem 2011; 286: 7257–7266.
Huang RP, Fan Y, de Belle I, Niemeyer C, Gottardis MM, Mercola D et al. Decreased Egr-1 expression in human, mouse and rat mammary cells and tissues correlates with tumor formation. Int J Cancer 1997; 72: 102–109.
Shields JM, Christy RJ, Yang VW . Identification and characterization of a gene encoding a gut-enriched Kruppel-like factor expressed during growth arrest. J Biol Chem 1996; 271: 20009–20017.
Xiao S, Li D, Zhu HQ, Song MG, Pan XR, Jia PM et al. RIG-G as a key mediator of the antiproliferative activity of interferon-related pathways through enhancing p21 and p27 proteins. Proc Natl Acad Sci USA 2006; 103: 16448–16453.
Acknowledgements
The research was supported by the ACS Research Scholar Grant (YP), gift from Swan family (YP), NIH RO1-CA151319 (CMC, PO1-CA81534 of the CLL Research Consortium (lZR, TJK, CMC) and AIL-sezione di Ferrara (lR). We thank Nyla A Heerema (The Ohio State University), Paola Dal Cin, Brigham & Women’s Hospital), Marie L Dell’ Aquila (Moores Cancer Center) Ayala Aviram (North Shore Hospital) and Daniel Van Dyke (Mayo Clinic) for cytogenetic analysis of CLL samples.
Author contributions
YP and CMC designed research; LZR, TJK, SL and MJK provided patient samples and clinical data; VB, AB, YP, AP, HA, LC and LR performed research and analyzed data; and YP, VB and CMC wrote the paper. All authors critically reviewed and edited the paper.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Leukemia website
Rights and permissions
About this article
Cite this article
Balatti, V., Lerner, S., Rizzotto, L. et al. Trisomy 12 CLLs progress through NOTCH1 mutations. Leukemia 27, 740–743 (2013). https://doi.org/10.1038/leu.2012.239
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2012.239
This article is cited by
-
NOTCH1 mutations identify a chronic lymphocytic leukemia patient subset with worse prognosis in the setting of a rituximab-based induction and consolidation treatment
Annals of Hematology (2014)
-
NOTCH1 and SF3B1 mutations can be added to the hierarchical prognostic classification in chronic lymphocytic leukemia
Leukemia (2013)